Ho-Keun Kwon

Ho-Keun Kwon

Auto-generated profile, based on publicly available information

Ho-Keun Kwon

Department of Microbiology and Immunology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2010 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
HKHo-Keun Kwon
Ho-Keun Kwon
CLChoong-Gu Lee
Choong-Gu Lee
JSJae-Seon So
Jae-Seon So
CCChang-Suk Chae
Chang-Suk Chae
JHJi-Sun Hwang
Ji-Sun Hwang
SISin-Hyeog Im
Sin-Hyeog Im
The beneficial effects of probiotics have been described in many diseases, but the mechanism by which they modulate the immune system is poorly understood. In this study, we identified a mixture of probiotics that up-regulates CD4 + Foxp3 + regulatory T cells (Tregs). Administration of the probiotics mixture induced both T-cell and B-cell hyporesponsiveness and down-regulated T helper (Th) 1, Th2, and Th17 cytokines without apoptosis induction. It also induced generation of CD4 + Foxp3 + Tregs from the CD4 + CD25 − population and increased the suppressor activity of naturally occurring CD4 + CD25 + Tregs. Conversion of T cells into Foxp3 + Tregs is directly mediated by regulatory dendritic cells (rDCs) that express high levels of IL-10, TGF-β, COX-2, and indoleamine 2,3-dioxygenase. Administration of probiotics had therapeutical effects in experimental inflammatory bowel disease, atopic dermatitis, and rheumatoid arthritis. The therapeutical effect of the probiotics is associated with enrichment of CD4 + Foxp3 + Tregs in the inflamed regions. Collectively, the administration of probiotics that enhance the generation of rDCs and Tregs represents an applicable treatment of inflammatory immune disorders.

12 September 2014 in Science
Verified
Journal Article
Closed access
PDF file
CYChun Jimmie Ye
Chun Jimmie Ye
TFTing Feng
Ting Feng
HKHo-Keun Kwon
Ho-Keun Kwon
TRTowfique Raj
Towfique Raj
MWMichael T. Wilson
Michael T. Wilson
CBChristophe Benoist
Christophe Benoist
Response to pathogens is in the genes: T cells are important in mounting immune responses to a host of pathogens, and they have also been implicated in autoimmune disease. By examining the variability in gene expression in stimulated T cells over time from a multi-ethnic cohort of healthy humans, Ye et al. identified specific genetic polymorphisms that explain differences among individuals in response to pathogens. Furthermore, a candidate gene approach led to the identification of a single-nucleotide polymorphism that controls the response of the autoimmune-associated IL2RA gene. This study helps us understand the degree to which immune responses are driven by the environment or by an individual's physiological or genetic factors. Science , this issue 10.1126/science.1254665

1 March 2013 in Clinical Immunology
Verified
Journal Article
Closed access
HKHo-Keun Kwon
Ho-Keun Kwon
GKGi-Cheon Kim
Gi-Cheon Kim
YKYoung Kim
Young Kim
WHWon Hwang
Won Hwang
AJArijita Jash
Arijita Jash
SISin-Hyeog Im
Sin-Hyeog Im

5 February 2022 in Trends in Immunology
Verified
Journal Article
Closed access
HKHo-Keun Kwon
Ho-Keun Kwon
GCGloria B. Choi
Gloria B. Choi
JHJun R. Huh
Jun R. Huh

14 August 2025 in Cellular & Molecular Immunology
Verified
Journal Article
Open access
PDF file
JPJohn Park
John Park
LCLeechung Chang
Leechung Chang
HKHo-Keun Kwon
Ho-Keun Kwon
SISin-Hyeog Im
Sin-Hyeog Im
Emerging research underscores the pivotal role of the gut–immune–brain axis, a dynamic bidirectional communication system involving intricate interactions between the gut microbiota, immune responses, and the central nervous system. Gut microbes and their metabolites have profound effects on immune and neurological homeostasis, influencing the development and function of multiple physiological systems. Disruption of the composition of the gut microbiota and barrier integrity has been implicated in various neurological and psychiatric disorders, including autism spectrum disorder, Alzheimer’s disease, Parkinson’s disease, depression, and anxiety. Most insights into these host–microbiota interactions come from preclinical models, revealing both the complexity and potential therapeutic opportunities of the gut–brain communication pathways. This review synthesizes the current understanding of these intricate interactions, exploring how microbiota-driven modulation of the gut and brain barriers, immune signaling, and neuronal pathways, such as those through the vagus nerve, contributes to health and disease. We further explore therapeutic implications, including personalized precision microbiota interventions, microbiome-derived biomarkers, and barrier-strengthening strategies. Advancing this field offers transformative potential for developing innovative, personalized therapies tailored to individual microbiomes and immune profiles, ultimately redefining clinical approaches to neurological and immune-mediated diseases.

29 July 2012 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
ILIn‐Hyun Lee
In‐Hyun Lee
HKHo‐Keun Kwon
Ho‐Keun Kwon
SASukyung An
Sukyung An
DKDaejin Kim
Daejin Kim
SKSunghyun Kim
Sunghyun Kim
SJSangyong Jon
Sangyong Jon